Direct-to-Consumer (DTC) Genetic Testing

Global Direct-to-Consumer (DTC) Genetic Testing Market to Reach US$3.4 Billion by 2030

The global market for Direct-to-Consumer (DTC) Genetic Testing estimated at US$1.5 Billion in the year 2024, is expected to reach US$3.4 Billion by 2030, growing at a CAGR of 14.0% over the analysis period 2024-2030. Single Nucleotide Polymorphism (SNP) Chips, one of the segments analyzed in the report, is expected to record a 13.6% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Targeted Analysis segment is estimated at 14.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$613.1 Million While China is Forecast to Grow at 16.6% CAGR

The Direct-to-Consumer (DTC) Genetic Testing market in the U.S. is estimated at US$613.1 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$269.8 Million by the year 2030 trailing a CAGR of 16.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.6% and 14.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.2% CAGR.

Global Direct-to-Consumer (DTC) Genetic Testing Market - Key Trends and Drivers Summarized

Direct-to-Consumer (DTC) genetic testing refers to genetic tests that are marketed directly to consumers without the need for an intermediary healthcare provider. These tests offer individuals insights into their genetic predispositions for a variety of issues, including risks for certain diseases, information about ancestry, and traits affecting wellness and nutrition. Consumers can purchase these tests online, collect a DNA sample using a kit typically involving saliva or a cheek swab, and send it back to the company for analysis. Results are usually accessed via a secure online account, providing detailed reports that explain the genetic findings and their potential implications. This model of genetic testing is aimed at increasing accessibility to genetic information and empowering consumers with knowledge about their health and heritage.

The DTC genetic testing market has expanded rapidly due to technological advances in genomics and a significant reduction in the cost of DNA analysis. Innovations in genetic sequencing technology and data analytics have made it possible for companies to offer these tests at a consumer-friendly price while ensuring a quick turnaround for results. The scope of tests has also broadened, with companies offering panels that can assess risk for hundreds of conditions or provide detailed genealogical histories. This accessibility invites consumers who are curious about their genetic makeup to explore their ancestry, understand their predisposition to certain health conditions, respond better to particular medications, or tailor their diet and lifestyle based on their genetic markers. As consumer awareness and interest grow, the demand for these personalized insights increases, pushing the market forward.

The growth in the DTC genetic testing market is driven by several factors. A key driver is the increasing consumer interest in personalized health and wellness. As people become more proactive about their health, they seek detailed information that could guide their lifestyle choices and medical decisions. Technological advancements that enhance the accuracy and depth of genetic analysis further stimulate market growth. Moreover, the growing trend of preventive healthcare and the potential of genetic testing to contribute to early disease detection and management attract more consumers. Regulatory developments also play a significant role, as clearer guidelines and approvals from bodies like the FDA boost consumer confidence in the validity and reliability of these tests. Additionally, marketing strategies that emphasize the empowerment of individuals to manage their health independently resonate strongly with modern healthcare consumers, who are increasingly inclined to take control of their health data and choices. As a result, the DTC genetic testing market continues to expand, driven by both technological innovation and evolving consumer behavior.

SCOPE OF STUDY:

The report analyzes the Direct-to-Consumer (DTC) Genetic Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Test Type (Ancestry & Relationship Testing, Nutrigenomics Testing, Predictive Testing, Carrier Testing, Other Test Types); Technology (Single Nucleotide Polymorphism (SNP) Chips, Targeted Analysis, Whole Genome Sequencing (WGS)); Distribution Channel (Online, Over-the-Counter)

Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Select Competitors (Total 81 Featured) -

• Ambry Genetics
• 23andMe, Inc.
• Ancestry.com LLC
• Any Lab Test Now
• Color Genomics, Inc.
• Direct Laboratory Services LLC (DirectLabs)
• DNA Diagnostics Center
• Anglia DNA Services
• Centrillion Technologies, Inc.,
• Dante Labs, Inc.
• Asper Biogene LLC
• Bou Trade Labs, S.L (24 genetics )
• African Ancestry, Inc.
• Chengdu 23Mofang Biotechnology Co., Ltd.
• Atlas Biomed Group Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.